June 2011 - Class Action Blog Archive
Oreck Halo Class Action May Be Possible for Vacuum, Air Cleaner Owners
Consumers who purchased an Oreck Halo vacuum or ProShield Plus air cleaner may be able to participate in an Oreck halo class action lawsuit against the company for allegedly false and deceptive marketing and advertising.
Uponor Plumbing Fittings "Unreasonably Dangerous" and "Defective"
Uponor, INC. and its subsidiary Radiant Technology, Inc. (RTI) are facing considerable pressure (no pun intended) after some of their brass plumbing fittings were reported to provide extremely low water pressure or to fail prematurely, causing considerable property damage to homes, buildings, and belongings.
Topamax Birth Defects Warning Released by FDA
Topamax (Topiramate) use by pregnant women significantly increases the risk of a child born with a cleft lip or cleft palate, according to an FDA report.
Drug Use During Pregnancy On the Rise, Says Study
According to a study published by the American Journal of Obstetrics and Gynecology, the use of prescription medication by pregnant women over the last three decades has drastically increased.
First Ceramic-on-Metal Hip Implant Approved
On June 13, the FDA approved the first ceramic-on-metal total artificial hip replacement for individuals with osteoarthritis. With the approval of the DePuy Pinnacle CoMplete Acetabular hip system, doctors now have an additional option for total hip replacement surgery.
Fosamax Linked to Rare Femur Fractures
The bisphosphonate Fosamax (alendronate) has been further linked to rare femur fractures in postmenstrual women, according to a new study by the New England Journal of Medicine.
FDA Initiates Probe into Possible Hip Replacement Metal Poisoning
The Food and Drug Administration (FDA) has continued to express worries about the negative effects of metal-on-metal hip replacement, recently ordering twenty-one hip manufacturers to conduct further studies into possible metal poisoning of patients.
Yaz Blood Clot Risk Being Investigated by FDA
Yaz, Yasmin, Beyaz and birth control pills similar to these are the subjects of a new FDA safety review initiated yesterday, May 31. Recent studies have suggested that these drugs could have two to three times the potential to cause blood clots in users when compared with other oral contraceptives.